Sopharma Trading AD closed 2021 achieving revenue of 957 154 ths. BGN which represents 9% growth compared to 877 811 ths. BGN аs per the 2020 audited report. The revenue in December only increased by 5% to 82 206 ths. BGN vs. 78 357 ths. BGN in the same month of the previous year.
The profit before taxes for 2021 amounts to 8,180 ths. BGN. The impairment test of the investment in the Serbian subsidiary Sopharma Trading d.o.o. carried out in accordance with IAS 36 “Impairment of assets” resulted in impairment loss of 17,307 ths. BGN. The accumulated profit before taxes of Sopharma Trading AD for the period January-December 2021 prior to the impact of the impairment loss reaches 25 487 ths. BGN.